Tests and diagnosis
A female fertility assessment is not a single test, but rather a set of evaluations that help assess ovarian reserve, hormonal function, the condition of the uterus and, when indicated, the patency of the fallopian tubes. The aim is to understand which factors may be making it more difficult to achieve pregnancy and which treatment options are most appropriate for each patient.
The assessment may include a medical consultation, a gynaecological ultrasound, antral follicle count, hormone tests, AMH testing, an assessment of the menstrual cycle and additional tests depending on the patient’s medical history. In some cases, genetic or immunological tests may also be recommended, as well as tests to assess the uterine cavity and fallopian tubes.
The results should always be interpreted by a specialist in assisted reproduction, as they depend on the patient’s age, medical history, how long she has been trying to conceive and her goal: to achieve pregnancy now, preserve fertility or plan motherhood for the future.
Early diagnosis is key to preventing infertility and increasing the chances of pregnancy.
Thanks to a female fertility study, the medical team can obtain a complete picture of ovarian, hormonal, and uterine function, and thus establish the personalized treatment best suited to each patient.
Performing a fertility study allows for:
It allows the assessment of the uterus, ovaries and antral follicle count, an indicator of ovarian reserve.
Hormones related to ovulation and ovarian quality are analyzed:
Radiological or ultrasound test to check if the fallopian tubes are patent and to assess the uterine cavity.
In some cases, genetic, immunological, or coagulation studies are performed for a more complete diagnosis.
After the tests, the medical team interprets the results individually and recommends the most appropriate treatment: artificial insemination, in vitro fertilization, egg donation, or other specific techniques for each case.
Each diagnosis is unique, so a fertility assessment is the first step in designing a customized treatment plan tailored to each patient's needs and characteristics. This individualized approach optimizes the chances of success and offers comprehensive medical care based on scientific evidence and emotional support throughout the entire process.
Most tests can be performed in one or two menstrual cycles.
Most tests, such as ultrasound scans and blood tests, are well tolerated. Some specific procedures, such as assessing fallopian tube patency or hysteroscopy, may cause some discomfort, so the medical team will explain beforehand how they are performed.
Some tests, such as hormone analyses, must be performed on specific days of the menstrual cycle. The specialist will indicate the best time.
It is advisable from the age of 35, although it can be done earlier in women with a medical history or who want to preserve eggs.
Ideally, a complete study of the couple should be performed. In the case of the male partner, a semen analysis is done.
It is recommended to seek advice if pregnancy has not been achieved after 12 months of unprotected intercourse, or after 6 months if the woman is over 35. A fertility assessment may also be useful in cases of irregular menstrual cycles, endometriosis, recurrent miscarriages, previous gynaecological surgery or a desire to preserve fertility.
Anti-Müllerian hormone, or AMH, helps estimate ovarian reserve. It does not predict the chances of pregnancy on its own, but it provides relevant information for planning treatment and assessing the expected response to ovarian stimulation.
At Institut Marquès, we have a team of specialist physicians and a leading Assisted Reproduction laboratory.
A female fertility assessment is the first step in designing the most appropriate treatment for you.
Request your first free consultation and have all your questions answered by our experts.
